The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis

Journal of Cell Biology

Volumn 188, Issue 6, 2010, Pages 905-918

  Herkert, Barbara ^a   Dwertmann, Anne ^a   Herold, Steffi ^a   Abed, Mona ^c   Naud, Jean Francois ^a   Finkernagel, Florian ^d   Harms, Gregory S ^b   Orian, Amir ^c   Wanzel, Michael ^d   Eilers, Martin ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; MIZ1 PROTEIN; MYC PROTEIN; NUCLEOPHOSMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; BINDING COMPETITION; CARCINOGENICITY; CELL ADHESION; CELL INTERACTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE REPRESSION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MUTATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUMOYLATION;

EID: 77949689758     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200908103     Document Type: Article

References (47)

1. Bertwistle, D., M. Sugimoto, and C.J. Sherr. 2004. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24:985-996. doi:10.1128/MCB.24.3.985- 996.2004
2. Chen, D., N. Kon, M. Li, W. Zhang, J. Qin, and W. Gu. 2005. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell. 121:1071-1083. doi:10.1016/j.cell.2005.03.037
3. Clark, P.A., S. Llanos, and G. Peters. 2002. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2. Oncogene. 21:4498-4507. doi:10.1038/sj.onc.1205558
4. Colombo, E., P. Bonetti, E. Lazzerini Denchi, P. Martinelli, R. Zamponi, J.C. Marine, K. Helin, B. Falini, and P.G. Pelicci. 2005. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol. Cell. Biol. 25:8874-8886. doi:10.1128/MCB.25.20.8874-8886.2005
5. Datta, A., A. Nag, W. Pan, N. Hay, A.L. Gartel, O. Colamonici, Y. Mori, and P. Raychaudhuri. 2004. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J. Biol. Chem. 279:36698-36707. doi:10.1074/jbc.M312305200
6. Dennis, G. Jr., B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, H.C. Lane, and R.A. Lempicki. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4:P3. doi:10.1186/gb-2003-4-5-p3
7. Eilers, M., and R.N. Eisenman. 2008. Myc's broad reach. Genes Dev. 22:2755-2766. doi:10.1101/gad.1712408
8. Frye, M., C. Gardner, E.R. Li, I. Arnold, and F.M. Watt. 2003. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development. 130:2793-2808. doi:10.1242/dev.00462
9. Gebhardt, A., M. Frye, S. Herold, S.A. Benitah, K. Braun, B. Samans, F.M. Watt, H.P. Elsässer, and M. Eilers. 2006. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J. Cell Biol. 172:139-149. doi:10.1083/jcb.200506057
10. Haindl, M., T. Harasim, D. Eick, and S. Muller. 2008. The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep. 9:273-279. doi:10.1038/embor. 2008.3
11. Herold, S., M. Wanzel, V. Beuger, C. Frohme, D. Beul, T. Hillukkala, J. Syvaoja, H.P. Saluz, F. Haenel, and M. Eilers. 2002. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol. Cell. 10:509-521. doi:10.1016/S1097-2765(02)00633-0
12. Herold, S., A. Hock, B. Herkert, K. Berns, J. Mullenders, R. Beijersbergen, R. Bernards, and M. Eilers. 2008. Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. EMBO J. 27:2851-2861. doi:10.1038/emboj.2008.200
13. Itahana, K., and Y. Zhang. 2008. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell. 13:542-553. doi:10.1016/j.ccr. 2008.04.002
14. Itahana, K., K.P. Bhat, A. Jin, Y. Itahana, D. Hawke, R. Kobayashi, and Y. Zhang. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell. 12:1151-1164. doi:10.1016/S1097-2765(03)00431-3
15. Kamijo, T., F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:649-659. doi:10.1016/S0092-8674(00)80452-3
16. Kamijo, T., J.D. Weber, G. Zambetti, F. Zindy, M.F. Roussel, and C.J. Sherr. 1998. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA. 95:8292-8297. doi:10.1073/pnas.95.14.8292
17. Kelly-Spratt, K.S., K.E. Gurley, Y. Yasui, and C.J. Kemp. 2004. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. PLoS Biol. 2:E242. doi:10.1371/journal.pbio.0020242
18. Korgaonkar, C., J. Hagen, V. Tompkins, A.A. Frazier, C. Allamargot, F.W. Quelle, and D.E. Quelle. 2005. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol. Cell. Biol. 25:1258-1271. doi:10.1128/MCB.25.4.1258-1271.2005
19. Kuo, M.L., W. den Besten, M.C. Thomas, and C.J. Sherr. 2008. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. Cell Cycle. 7:3378-3387.
20. Li, Z., D. Boone, and S.R. Hann. 2008. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc. Natl. Acad. Sci. USA. 105:18794-18799. doi:10.1073/pnas.0806879105
21. Maggi, L.B. Jr., M. Kuchenruether, D.Y. Dadey, R.M. Schwope, S. Grisendi, R.R. Townsend, P.P. Pandolfi, and J.D. Weber. 2008. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol. Cell. Biol. 28:7050-7065. doi:10.1128/MCB.01548-07
22. Miao, L., Z. Song, L. Jin, Y.M. Zhu, L.P. Wen, and M. Wu. 2010. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation. Oncogene. 29:711-722. doi:10.1038/onc.2009.372
23. Orian-Rousseau, V., L. Chen, J.P. Sleeman, P. Herrlich, and H. Ponta. 2002. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16:3074-3086. doi:10.1101/gad.242602
24. Oster, S.K., C.S. Ho, E.L. Soucie, and L.Z. Penn. 2002. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84:81-154. doi:10.1016/S0065- 230X(02)84004-0
25. Ouyang, J., Y. Shi, A. Valin, Y. Xuan, and G. Gill. 2009. Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol. Cell. 34:145-154. doi:10.1016/j.molcel. 2009.03.013
26. Park, Y.B., M.J. Park, K. Kimura, K. Shimizu, S.H. Lee, and J. Yokota. 2002. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet. Cytogenet. 133:105-111. doi:10.1016/S0165-4608(01)00575-1
27. Patel, J.H., and S.B. McMahon. 2007. BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. J. Biol. Chem. 282:5-13. doi:10.1074/jbc.M609138200
28. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396. doi:10.1073/pnas.90.18.8392
29. Peukert, K., P. Staller, A. Schneider, G. Carmichael, F. Hänel, and M. Eilers. 1997. An alternative pathway for gene regulation by Myc. EMBO J. 16:5672-5686. doi:10.1093/emboj/16.18.5672
30. Qi, Y., M.A. Gregory, Z. Li, J.P. Brousal, K. West, and S.R. Hann. 2004. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature. 431:712-717. doi:10.1038/nature02958
31. Quelle, D.E., F. Zindy, R.A. Ashmun, and C.J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:993-1000. doi:10.1016/0092-8674(95)90214-7
32. Reginato, M.J., K.R. Mills, J.K. Paulus, D.K. Lynch, D.C. Sgroi, J. Debnath, S.K. Muthuswamy, and J.S. Brugge. 2003. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol. 5:733-740. doi:10.1038/ncb1026
33. Salghetti, S.E., S.Y. Kim, and W.P. Tansey. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18:717-726. doi:10.1093/emboj/18.3.717
34. Seoane, J., C. Pouponnot, P. Staller, M. Schader, M. Eilers, and J. Massagué. 2001. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3:400-408. doi:10.1038/35070086
35. Seoane, J., H.V. Le, and J. Massagué. 2002. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 419:729-734. doi:10.1038/nature01119
36. Staller, P., K. Peukert, A. Kiermaier, J. Seoane, J. Lukas, H. Karsunky, T. Möröy, J. Bartek, J. Massagué, F. Hänel, and M. Eilers. 2001. Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3:392-399. doi:10.1038/35070076
37. Stielow, B., A. Sapetschnig, I. Krüger, N. Kunert, A. Brehm, M. Boutros, and G. Suske. 2008. Identification of SUMO-dependent chromatin-associated transcriptional repression components by a genome-wide RNAi screen. Mol. Cell. 29:742-754. doi:10.1016/j.molcel.2007.12.032
38. Stott, F.J., S. Bates, M.C. James, B.B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K.H. Vousden, and G. Peters. 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:5001-5014. doi:10.1093/emboj/17.17.5001
39. Tago, K., S. Chiocca, and C.J. Sherr. 2005. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc. Natl. Acad. Sci. USA. 102:7689-7694. doi:10.1073/pnas.0502978102
40. Wanzel, M., A.C. Russ, D. Kleine-Kohlbrecher, E. Colombo, P.G. Pelicci, and M. Eilers. 2008. A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat. Cell Biol. 10:1051-1061. doi:10.1038/ncb1764
41. Weber, J.D., J.R. Jeffers, J.E. Rehg, D.H. Randle, G. Lozano, M.F. Roussel, C.J. Sherr, and G.P. Zambetti. 2000. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14:2358-2365. doi:10.1101/gad. 827300
42. Wei, C.L., Q. Wu, V.B. Vega, K.P. Chiu, P. Ng, T. Zhang, A. Shahab, H.C. Yong, Y. Fu, Z. Weng, et al. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell. 124:207-219. doi:10.1016/j.cell.2005.10.043
43. Wettenhall, J.M., and G.K. Smyth. 2004. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 20:3705-3706. doi:10.1093/bioinformatics/bth449
44. Wilson, A., M.J. Murphy, T. Oskarsson, K. Kaloulis, M.D. Bettess, G.M. Oser, A.C. Pasche, C. Knabenhans, H.R. Macdonald, and A. Trumpp. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18:2747-2763. doi:10.1101/gad.313104
45. Zhang, Y., Y. Xiong, and W.G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:725-734. doi:10.1016/S0092- 8674(00)81401-4
46. Zindy, F., C.M. Eischen, D.H. Randle, T. Kamijo, J.L. Cleveland, C.J. Sherr, and M.F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424-2433. doi:10.1101/gad.12.15.2424
47. Zindy, F., R.T. Williams, T.A. Baudino, J.E. Rehg, S.X. Skapek, J.L. Cleveland, M.F. Roussel, and C.J. Sherr. 2003. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc. Natl. Acad. Sci. USA. 100:15930-15935. doi:10.1073/pnas.2536808100